{ "updated": "2026-05-20", "disclosure": "Source links are normalized for citation and audit. Internal Peptide Checker pages are labelled internal; third-party source pages are labelled external.", "sourceCount": 99, "sources": [ { "url": "https://abr.business.gov.au/", "label": "Australian Business Register - ABN Lookup", "sourceType": "external", "usedBy": [ { "type": "guide", "title": "ABN and Operator Identity Check for Peptide Vendors", "url": "https://peptidecheck.com.au/guides/abn-operator-identity-check-peptides-australia/", "context": "How Australian peptide buyers can check ABN, business names, operator visibility, contact details, domain identity, and correction evidence before trusting a vendor." }, { "type": "market-source", "title": "State of the Australian peptide market", "url": "https://peptidecheck.com.au/state-of-market/", "context": "The Australian Business Register provides ABN Lookup for checking registered business names, ABN status, and entity details." } ], "usedByCount": 2 }, { "url": "https://aems.tga.gov.au/daen-medicines-search/", "label": "DAEN medicines search", "sourceType": "external", "usedBy": [ { "type": "regulatory", "title": "Peptide Adverse Event Reporting Australia", "url": "https://peptidecheck.com.au/regulatory/adverse-event-reporting-peptides-australia/", "context": "The TGA's Database of Adverse Event Notifications, DAEN, is a public database of adverse event reports for medicines and vaccines. A report in DAEN does not prove that a medicine caused the event, but it can show safety signals that deserve careful review. Peptide Checker uses this page to explain what evidence buyers should preserve if they suspect harm from a peptide product." } ], "usedByCount": 1 }, { "url": "https://alphaedgeclinic.com.au/pages/repair-regeneration-therapies", "label": "Alpha Edge Clinic repair and regeneration therapies page", "sourceType": "external", "usedBy": [ { "type": "vendor", "title": "Alpha Edge Clinic", "url": "https://peptidecheck.com.au/vendors/alpha-edge-clinic/", "context": "Public Alpha Edge Clinic repair and regeneration page recorded 2026-05-19." } ], "usedByCount": 1 }, { "url": "https://au.peptislim.com/", "label": "PeptiSlim Australia - Homepage", "sourceType": "external", "usedBy": [ { "type": "market-source", "title": "State of the Australian peptide market", "url": "https://peptidecheck.com.au/state-of-market/", "context": "PeptiSlim Australia says research peptides are delivered from Australia with COAs, batch numbers, HPLC verification, Express Post, and card checkout." }, { "type": "vendor", "title": "PeptiSlim Australia", "url": "https://peptidecheck.com.au/vendors/peptislim-australia/", "context": "Public PeptiSlim Australia homepage recorded 2026-05-19." } ], "usedByCount": 2 }, { "url": "https://ausbiopeps.com/", "label": "Aus Bio Peps - Homepage", "sourceType": "external", "usedBy": [ { "type": "market-source", "title": "State of the Australian peptide market", "url": "https://peptidecheck.com.au/state-of-market/", "context": "Aus Bio Peps presents Australian research peptide supply with 99%+ purity via HPLC and MS testing, express shipping, local support, and secure ordering claims." }, { "type": "vendor", "title": "Aus Bio Peps", "url": "https://peptidecheck.com.au/vendors/aus-bio-peps/", "context": "Public Aus Bio Peps homepage recorded 2026-05-19." } ], "usedByCount": 2 }, { "url": "https://auspep.com.au/about-us/", "label": "AUSPEP about page", "sourceType": "external", "usedBy": [ { "type": "vendor", "title": "AUSPEP", "url": "https://peptidecheck.com.au/vendors/auspep/", "context": "Public AUSPEP website pages crawled May 2026." }, { "type": "vendor", "title": "AUSPEP", "url": "https://peptidecheck.com.au/vendors/auspep/", "context": "Ownership transparency: AUSPEP's about and history pages provide public operator context." }, { "type": "vendor", "title": "AUSPEP", "url": "https://peptidecheck.com.au/vendors/auspep/", "context": "Founder visibility: The current evidence is operator-level rather than founder-on-camera evidence." } ], "usedByCount": 3 }, { "url": "https://auspep.com.au/compliance-regulatory-support/", "label": "AUSPEP compliance and regulatory support", "sourceType": "external", "usedBy": [ { "type": "vendor", "title": "AUSPEP", "url": "https://peptidecheck.com.au/vendors/auspep/", "context": "Public AUSPEP website pages crawled May 2026." }, { "type": "vendor", "title": "AUSPEP", "url": "https://peptidecheck.com.au/vendors/auspep/", "context": "TGA enforcement history: Public AUSPEP pages state TGA registration, GMP accreditation, and routine TGA inspection. Peptide Lab does not claim this dimension." } ], "usedByCount": 2 }, { "url": "https://auspep.com.au/history/", "label": "AUSPEP history", "sourceType": "external", "usedBy": [ { "type": "vendor", "title": "AUSPEP", "url": "https://peptidecheck.com.au/vendors/auspep/", "context": "Public AUSPEP website pages crawled May 2026." }, { "type": "vendor", "title": "AUSPEP", "url": "https://peptidecheck.com.au/vendors/auspep/", "context": "Years in business: AUSPEP's history page states the business was established in 1987." }, { "type": "vendor", "title": "AUSPEP", "url": "https://peptidecheck.com.au/vendors/auspep/", "context": "Ownership transparency: AUSPEP's about and history pages provide public operator context." }, { "type": "vendor", "title": "AUSPEP", "url": "https://peptidecheck.com.au/vendors/auspep/", "context": "Australian operation: AUSPEP's public pages describe an Australian GMP peptide manufacturing operation." } ], "usedByCount": 4 }, { "url": "https://auspep.com.au/products/", "label": "AUSPEP products page", "sourceType": "external", "usedBy": [ { "type": "vendor", "title": "AUSPEP", "url": "https://peptidecheck.com.au/vendors/auspep/", "context": "Public AUSPEP website pages crawled May 2026." }, { "type": "vendor", "title": "AUSPEP", "url": "https://peptidecheck.com.au/vendors/auspep/", "context": "Public batch records: AUSPEP is scored as a regulated manufacturer, not a retail-style public batch lookup. A retail-buyer batch record audit remains separate." }, { "type": "vendor", "title": "AUSPEP", "url": "https://peptidecheck.com.au/vendors/auspep/", "context": "TGA enforcement history: Public AUSPEP pages state TGA registration, GMP accreditation, and routine TGA inspection. Peptide Lab does not claim this dimension." }, { "type": "vendor", "title": "AUSPEP", "url": "https://peptidecheck.com.au/vendors/auspep/", "context": "Site clarity and terms: The public products, compliance, history, and about pages give clearer context than a generic retail peptide landing page." }, { "type": "vendor", "title": "AUSPEP", "url": "https://peptidecheck.com.au/vendors/auspep/", "context": "Australian operation: AUSPEP's public pages describe an Australian GMP peptide manufacturing operation." }, { "type": "vendor", "title": "AUSPEP", "url": "https://peptidecheck.com.au/vendors/auspep/", "context": "Product diversity: AUSPEP publishes a broad peptide/API manufacturing and custom synthesis offering." } ], "usedByCount": 6 }, { "url": "https://aussiepeptidehub.com.au/", "label": "Aussie Peptide Hub - Homepage", "sourceType": "external", "usedBy": [ { "type": "market-source", "title": "State of the Australian peptide market", "url": "https://peptidecheck.com.au/state-of-market/", "context": "Aussie Peptide Hub says products are third-party tested at 99%+ purity, COAs are available upon request, and products ship from within Australia." }, { "type": "vendor", "title": "Aussie Peptide Hub", "url": "https://peptidecheck.com.au/vendors/aussie-peptide-hub/", "context": "Public Aussie Peptide Hub homepage recorded 2026-05-19." } ], "usedByCount": 2 }, { "url": "https://australia.direct-sarms.com/product/bpc-157-peptide-vial/", "label": "Direct SARMS Australia BPC-157 product page", "sourceType": "external", "usedBy": [ { "type": "vendor", "title": "Direct SARMS Australia", "url": "https://peptidecheck.com.au/vendors/direct-sarms/", "context": "Public Direct SARMS Australia product page and search-demand review, 2026-05-17." }, { "type": "vendor", "title": "Direct SARMS Australia", "url": "https://peptidecheck.com.au/vendors/direct-sarms/", "context": "Site clarity and terms: The BPC-157 product page is recorded as a source for research-use disclaimers, product claims, and ecommerce behaviour." }, { "type": "vendor", "title": "Direct SARMS Australia", "url": "https://peptidecheck.com.au/vendors/direct-sarms/", "context": "Pricing transparency: The recorded product page shows ecommerce pricing and add-to-cart behaviour for vial-size options." } ], "usedByCount": 3 }, { "url": "https://australia.pharmalabglobal.com/", "label": "Pharma Lab Global Australia homepage", "sourceType": "external", "usedBy": [ { "type": "vendor", "title": "Pharma Lab Global Australia", "url": "https://peptidecheck.com.au/vendors/pharma-lab-global-australia/", "context": "Public Pharma Lab Global Australia homepage recorded 2026-05-19." } ], "usedByCount": 1 }, { "url": "https://australianpeptidestore.com.au/product/bpc-157-tb-500-blend-10mg-australian-peptides-store/", "label": "Australian Peptide Store BPC-157/TB-500 product page", "sourceType": "external", "usedBy": [ { "type": "vendor", "title": "Australian Peptide Store", "url": "https://peptidecheck.com.au/vendors/australian-peptide-store/", "context": "Public Australian Peptide Store product page recorded 2026-05-19." } ], "usedByCount": 1 }, { "url": "https://australianpeptidestore.com.au/shop/", "label": "Australian Peptide Store shop page", "sourceType": "external", "usedBy": [ { "type": "vendor", "title": "Australian Peptide Store", "url": "https://peptidecheck.com.au/vendors/australian-peptide-store/", "context": "Public Australian Peptide Store product page recorded 2026-05-19." } ], "usedByCount": 1 }, { "url": "https://bt7.com.au/", "label": "BT-7 - Homepage", "sourceType": "external", "usedBy": [ { "type": "market-source", "title": "State of the Australian peptide market", "url": "https://peptidecheck.com.au/state-of-market/", "context": "BT-7 publishes research peptide category navigation, 24-hour dispatch language, third-party-testing language, and a reconstitution calculator." }, { "type": "vendor", "title": "BT-7", "url": "https://peptidecheck.com.au/vendors/bt-7/", "context": "Public BT-7 homepage recorded 2026-05-19." } ], "usedByCount": 2 }, { "url": "https://clarascience.com/", "label": "ClaraScience - Homepage", "sourceType": "external", "usedBy": [ { "type": "market-source", "title": "State of the Australian peptide market", "url": "https://peptidecheck.com.au/state-of-market/", "context": "ClaraScience presents itself as Australian owned, research-use-only, batch verified, HPLC tested, and shipped from an Australian warehouse." }, { "type": "vendor", "title": "ClaraScience", "url": "https://peptidecheck.com.au/vendors/clara-science/", "context": "Public ClaraScience homepage recorded 2026-05-19." } ], "usedByCount": 2 }, { "url": "https://comowellness.com.au/peptides/", "label": "Como Wellness peptide page", "sourceType": "external", "usedBy": [ { "type": "vendor", "title": "Como Wellness", "url": "https://peptidecheck.com.au/vendors/como-wellness/", "context": "Public Como Wellness peptide page recorded 2026-05-19." } ], "usedByCount": 1 }, { "url": "https://completepeptides.au/", "label": "CompletePeptides - Homepage", "sourceType": "external", "usedBy": [ { "type": "guide", "title": "Peptide COA Library Verification Standard", "url": "https://peptidecheck.com.au/guides/coa-library-verification-standard/", "context": "How to audit a peptide vendor's COA library, certificate links, batch reports, lab identity, test dates, HPLC data, and product-to-vial matching before trusting purity claims." }, { "type": "market-source", "title": "State of the Australian peptide market", "url": "https://peptidecheck.com.au/state-of-market/", "context": "CompletePeptides presents Australian fulfilment, independently tested batches, published COAs, ISO 17025 lab language, cold-chain shipping, and 48-hour dispatch claims." }, { "type": "vendor", "title": "CompletePeptides", "url": "https://peptidecheck.com.au/vendors/complete-peptides/", "context": "Public CompletePeptides homepage recorded 2026-05-19." } ], "usedByCount": 3 }, { "url": "https://everwellmedical.store/", "label": "Everwell Medical - Homepage", "sourceType": "external", "usedBy": [ { "type": "market-source", "title": "State of the Australian peptide market", "url": "https://peptidecheck.com.au/state-of-market/", "context": "Everwell Medical presents Australian research peptides with 98%+ purity, third-party lab testing, COA with every batch, shipment protection, and AU-wide shipping claims." }, { "type": "vendor", "title": "Everwell Medical", "url": "https://peptidecheck.com.au/vendors/everwell-medical/", "context": "Public Everwell Medical homepage recorded 2026-05-19." } ], "usedByCount": 2 }, { "url": "https://glvitalitydrips.com.au/peptides/", "label": "GL Vitality Drips peptide page", "sourceType": "external", "usedBy": [ { "type": "vendor", "title": "GL Vitality Drips", "url": "https://peptidecheck.com.au/vendors/gl-vitality-drips/", "context": "Public GL Vitality Drips peptide page recorded 2026-05-19." } ], "usedByCount": 1 }, { "url": "https://honehealth.com/edge/longevity-trends/", "label": "Hone Health - 26 Longevity Trends That Will Define 2026", "sourceType": "external", "usedBy": [ { "type": "market-source", "title": "State of the Australian peptide market", "url": "https://peptidecheck.com.au/state-of-market/", "context": "Lists peptides and regenerative aesthetics as watched 2026 longevity and recovery trends." } ], "usedByCount": 1 }, { "url": "https://odezion.com/", "label": "Odezion - Homepage", "sourceType": "external", "usedBy": [ { "type": "market-source", "title": "State of the Australian peptide market", "url": "https://peptidecheck.com.au/state-of-market/", "context": "Odezion presents research and pharmacy-grade peptide supply with up-to-date COAs, HPLC-MS testing, express shipping, and same-day dispatch claims." }, { "type": "vendor", "title": "Odezion", "url": "https://peptidecheck.com.au/vendors/odezion/", "context": "Public Odezion homepage recorded 2026-05-19." } ], "usedByCount": 2 }, { "url": "https://oztidelab.com/", "label": "OzTideLab - Homepage", "sourceType": "external", "usedBy": [ { "type": "guide", "title": "BPC-157 Price Check Australia", "url": "https://peptidecheck.com.au/guides/bpc-157-price-check-australia/", "context": "A dated price-intelligence snapshot for Australian BPC-157 searches, showing why cheap peptide pricing still needs batch, COA, lab, dispatch, and payment proof." }, { "type": "market-source", "title": "State of the Australian peptide market", "url": "https://peptidecheck.com.au/state-of-market/", "context": "OzTideLab presents Australian-owned research peptide supply, HPLC-verified purity of 98% or higher, and domestic shipping claims." }, { "type": "vendor", "title": "OzTideLab", "url": "https://peptidecheck.com.au/vendors/oztide-lab/", "context": "Public OzTideLab homepage recorded 2026-05-19." } ], "usedByCount": 3 }, { "url": "https://pepclab.com.au/", "label": "PepC.Labs - Homepage", "sourceType": "external", "usedBy": [ { "type": "guide", "title": "ABN and Operator Identity Check for Peptide Vendors", "url": "https://peptidecheck.com.au/guides/abn-operator-identity-check-peptides-australia/", "context": "How Australian peptide buyers can check ABN, business names, operator visibility, contact details, domain identity, and correction evidence before trusting a vendor." }, { "type": "guide", "title": "Peptide COA Library Verification Standard", "url": "https://peptidecheck.com.au/guides/coa-library-verification-standard/", "context": "How to audit a peptide vendor's COA library, certificate links, batch reports, lab identity, test dates, HPLC data, and product-to-vial matching before trusting purity claims." }, { "type": "market-source", "title": "State of the Australian peptide market", "url": "https://peptidecheck.com.au/state-of-market/", "context": "PepC.Labs presents Australian research peptides with ABN, same-day Sydney dispatch, COA every batch, and 99%+ HPLC purity claims." }, { "type": "vendor", "title": "PepC.Labs", "url": "https://peptidecheck.com.au/vendors/pep-c-labs/", "context": "Public PepC.Labs homepage recorded 2026-05-19." } ], "usedByCount": 4 }, { "url": "https://peptidecentre.com/", "label": "Peptide Centre - Homepage", "sourceType": "external", "usedBy": [ { "type": "guide", "title": "BPC-157 Price Check Australia", "url": "https://peptidecheck.com.au/guides/bpc-157-price-check-australia/", "context": "A dated price-intelligence snapshot for Australian BPC-157 searches, showing why cheap peptide pricing still needs batch, COA, lab, dispatch, and payment proof." }, { "type": "market-source", "title": "State of the Australian peptide market", "url": "https://peptidecheck.com.au/state-of-market/", "context": "Peptide Centre publishes a peptide catalogue including BPC-157, TB-500, GHK-Cu, MOTS-C, NAD+, GLP peptides, growth-hormone peptides, and blends." }, { "type": "vendor", "title": "Peptide Centre", "url": "https://peptidecheck.com.au/vendors/peptide-centre/", "context": "Public Peptide Centre homepage recorded 2026-05-19." } ], "usedByCount": 3 }, { "url": "https://peptidecheck.com.au/about/", "label": "Peptide Checker ownership disclosure", "sourceType": "internal", "usedBy": [ { "type": "vendor", "title": "Peptide Lab", "url": "https://peptidecheck.com.au/vendors/peptide-lab/", "context": "Internal Peptide Lab product and batch records, 2026-05-17." }, { "type": "vendor", "title": "Peptide Lab", "url": "https://peptidecheck.com.au/vendors/peptide-lab/", "context": "Ownership transparency: Peptide Checker publicly discloses that it is operated by Peptide Lab Pty Ltd, including on the about page and footer." }, { "type": "vendor", "title": "Peptide Lab", "url": "https://peptidecheck.com.au/vendors/peptide-lab/", "context": "Australian operation: Peptide Checker discloses an Australian retail operator. AU fulfilment and entity records still need separate dated sources." } ], "usedByCount": 3 }, { "url": "https://peptidecheck.com.au/batch-ledger.json", "label": "Batch ledger JSON", "sourceType": "internal", "usedBy": [ { "type": "vendor", "title": "Peptide Lab", "url": "https://peptidecheck.com.au/vendors/peptide-lab/", "context": "Public batch records: The current Peptide Checker static ledger includes visible Peptide Lab batch examples. External COA audit still needs to be attached record by record." } ], "usedByCount": 1 }, { "url": "https://peptidecheck.com.au/methodology/", "label": "Peptide Checker methodology", "sourceType": "internal", "usedBy": [ { "type": "vendor", "title": "Direct SARMS Australia", "url": "https://peptidecheck.com.au/vendors/direct-sarms/", "context": "Public Direct SARMS Australia product page and search-demand review, 2026-05-17." }, { "type": "vendor", "title": "Peptide Lab", "url": "https://peptidecheck.com.au/vendors/peptide-lab/", "context": "Internal Peptide Lab product and batch records, 2026-05-17." }, { "type": "vendor", "title": "Peptide Lab", "url": "https://peptidecheck.com.au/vendors/peptide-lab/", "context": "Ownership transparency: Peptide Checker publicly discloses that it is operated by Peptide Lab Pty Ltd, including on the about page and footer." }, { "type": "vendor", "title": "Peptide Sciences", "url": "https://peptidecheck.com.au/vendors/peptide-sciences/", "context": "Secondary public shutdown coverage reviewed 2026-05-19." } ], "usedByCount": 4 }, { "url": "https://peptidecheck.com.au/right-of-reply/", "label": "Right of reply", "sourceType": "internal", "usedBy": [ { "type": "vendor", "title": "Direct SARMS Australia", "url": "https://peptidecheck.com.au/vendors/direct-sarms/", "context": "Right of reply respected: Correction outreach has not been logged for this vendor yet." }, { "type": "vendor", "title": "Peptide Lab", "url": "https://peptidecheck.com.au/vendors/peptide-lab/", "context": "Right of reply respected: Peptide Lab is the disclosed operator. The live correction process still matters for competitor pages and external corrections." } ], "usedByCount": 2 }, { "url": "https://peptidecheck.com.au/vendors/peptide-sciences/", "label": "Peptide Sciences incident page", "sourceType": "internal", "usedBy": [ { "type": "guide", "title": "Peptide Order Not Received Chargeback Australia", "url": "https://peptidecheck.com.au/guides/peptide-order-not-received-chargeback-australia/", "context": "What Australian peptide buyers should preserve when an order is not shipped, a vendor closes, a parcel is missing, or a support team stops replying." }, { "type": "regulatory", "title": "Peptide Sciences Shutdown Australia Search Guide", "url": "https://peptidecheck.com.au/regulatory/peptide-sciences-shutdown-australia/", "context": "Peptide Dossier reports Peptide Sciences shut down on 6 March 2026, gave no guidance for pending orders, had operated for more than a decade, and generated an estimated US$7.4M in monthly online sales as of December 2025 according to Grips Intelligence. Peptide Checker tracks it as a closed-vendor incident page, not as an active AU supplier." } ], "usedByCount": 2 }, { "url": "https://peptidedossier.com/guides/peptide-sciences-shutdown/", "label": "Peptide Dossier - Peptide Sciences shutdown analysis", "sourceType": "external", "usedBy": [ { "type": "regulatory", "title": "Peptide Sciences Shutdown Australia Search Guide", "url": "https://peptidecheck.com.au/regulatory/peptide-sciences-shutdown-australia/", "context": "Peptide Dossier reports Peptide Sciences shut down on 6 March 2026, gave no guidance for pending orders, had operated for more than a decade, and generated an estimated US$7.4M in monthly online sales as of December 2025 according to Grips Intelligence. Peptide Checker tracks it as a closed-vendor incident page, not as an active AU supplier." }, { "type": "market-source", "title": "State of the Australian peptide market", "url": "https://peptidecheck.com.au/state-of-market/", "context": "Secondary source reporting the March 2026 Peptide Sciences shutdown, pending-order uncertainty, and the reported Grips Intelligence revenue estimate." }, { "type": "vendor", "title": "Peptide Sciences", "url": "https://peptidecheck.com.au/vendors/peptide-sciences/", "context": "Secondary public shutdown coverage reviewed 2026-05-19." } ], "usedByCount": 3 }, { "url": "https://peptidehelp.com.au/", "label": "Peptide Help Australia - Homepage", "sourceType": "external", "usedBy": [ { "type": "market-source", "title": "State of the Australian peptide market", "url": "https://peptidecheck.com.au/state-of-market/", "context": "Peptide Help Australia presents itself as an independent information platform and says it does not sell, import, or supply peptides." }, { "type": "vendor", "title": "Peptide Help Australia", "url": "https://peptidecheck.com.au/vendors/peptide-help-australia/", "context": "Public Peptide Help Australia homepage recorded 2026-05-19." } ], "usedByCount": 2 }, { "url": "https://peptides-australia.net/", "label": "Peptides Australia - Homepage", "sourceType": "external", "usedBy": [ { "type": "market-source", "title": "State of the Australian peptide market", "url": "https://peptidecheck.com.au/state-of-market/", "context": "Peptides Australia is included as a Cloudflare-protected check in progress because direct record returned a protection response in this pass." }, { "type": "vendor", "title": "Peptides Australia", "url": "https://peptidecheck.com.au/vendors/peptides-australia/", "context": "Domain and public-search presence checked 2026-05-19; direct bot record returned HTTP 503." } ], "usedByCount": 2 }, { "url": "https://peptidesdirect.com.au/", "label": "Peptides Direct - Homepage", "sourceType": "external", "usedBy": [ { "type": "market-source", "title": "State of the Australian peptide market", "url": "https://peptidecheck.com.au/state-of-market/", "context": "Peptides Direct says its medical team specialises in Australian peptides, medication, and supplements and describes registration, screening, treatment plan, compounding, and dispatch." }, { "type": "vendor", "title": "Peptides Direct", "url": "https://peptidecheck.com.au/vendors/peptides-direct/", "context": "Public Peptides Direct homepage recorded 2026-05-19." } ], "usedByCount": 2 }, { "url": "https://peptidex.com.au/", "label": "PeptideX - Homepage", "sourceType": "external", "usedBy": [ { "type": "market-source", "title": "State of the Australian peptide market", "url": "https://peptidecheck.com.au/state-of-market/", "context": "PeptideX homepage metadata says it sells research peptides online in Australia with 99%+ purity, GMP-manufactured peptides, batch-specific COAs, and fast Australia-wide shipping." }, { "type": "vendor", "title": "PeptideX", "url": "https://peptidecheck.com.au/vendors/peptidex/", "context": "Public PeptideX homepage metadata recorded 2026-05-19." } ], "usedByCount": 2 }, { "url": "https://phyx.com.au/", "label": "PHYX - Homepage", "sourceType": "external", "usedBy": [ { "type": "guide", "title": "Clinic and Telehealth Peptide Pathway Check", "url": "https://peptidecheck.com.au/guides/clinic-telehealth-peptide-pathway-check/", "context": "How to inspect Australian peptide clinic, telehealth, pharmacy, prescription, practitioner, and compounding claims before trusting a medical pathway." }, { "type": "market-source", "title": "State of the Australian peptide market", "url": "https://peptidecheck.com.au/state-of-market/", "context": "PHYX presents longevity and personalised healthcare pathways across weight loss, anti-ageing, injury repair, muscle building, mood, sleep, gut, and sexual performance categories." }, { "type": "vendor", "title": "PHYX", "url": "https://peptidecheck.com.au/vendors/phyx/", "context": "Public PHYX homepage recorded 2026-05-19." } ], "usedByCount": 3 }, { "url": "https://platinumresearchcompounds.com/", "label": "Platinum Research Compounds - Homepage", "sourceType": "external", "usedBy": [ { "type": "market-source", "title": "State of the Australian peptide market", "url": "https://peptidecheck.com.au/state-of-market/", "context": "Platinum Research Compounds presents itself as a SARMs and peptides supplier and lists products including BPC-157, TB-500, IGF-1 LR3, CJC 1295 DAC, Ipamorelin, Retatrutide, Epitalon, MOTS-C, Tesamorelin, and NAD+." }, { "type": "vendor", "title": "Platinum Research Compounds", "url": "https://peptidecheck.com.au/vendors/platinum-research-compounds/", "context": "Public Platinum Research Compounds homepage recorded 2026-05-19." } ], "usedByCount": 2 }, { "url": "https://primelabsau.com/", "label": "Prime Labs AU - Homepage", "sourceType": "external", "usedBy": [ { "type": "market-source", "title": "State of the Australian peptide market", "url": "https://peptidecheck.com.au/state-of-market/", "context": "Prime Labs AU publishes research-use-only disclaimers and says products are not approved for human or animal consumption or therapeutic, diagnostic, or medicinal use." }, { "type": "vendor", "title": "Prime Labs AU", "url": "https://peptidecheck.com.au/vendors/prime-labs-au/", "context": "Public Prime Labs AU homepage recorded 2026-05-19." } ], "usedByCount": 2 }, { "url": "https://purepeptidesaustralia.com/pages/about-us", "label": "Pure Peptides Australia - About us", "sourceType": "external", "usedBy": [ { "type": "market-source", "title": "State of the Australian peptide market", "url": "https://peptidecheck.com.au/state-of-market/", "context": "Pure Peptides Australia says it is an Australian-based supplier of research peptides with third-party testing, documentation, COAs, and batch documentation." }, { "type": "vendor", "title": "Pure Peptides Australia", "url": "https://peptidecheck.com.au/vendors/pure-peptides-australia/", "context": "Public Pure Peptides Australia about page recorded 2026-05-19." } ], "usedByCount": 2 }, { "url": "https://researchchemsaustralia.com.au/", "label": "Research Chems Australia - Homepage", "sourceType": "external", "usedBy": [ { "type": "guide", "title": "Peptide Order Not Received Chargeback Australia", "url": "https://peptidecheck.com.au/guides/peptide-order-not-received-chargeback-australia/", "context": "What Australian peptide buyers should preserve when an order is not shipped, a vendor closes, a parcel is missing, or a support team stops replying." }, { "type": "market-source", "title": "State of the Australian peptide market", "url": "https://peptidecheck.com.au/state-of-market/", "context": "Research Chems Australia states the business has now closed and says orders and pre-orders placed before closing will be fulfilled." }, { "type": "vendor", "title": "Research Chems Australia", "url": "https://peptidecheck.com.au/vendors/research-chems-australia/", "context": "Public Research Chems Australia homepage recorded 2026-05-19." } ], "usedByCount": 3 }, { "url": "https://sarmnation.com/", "label": "SARM Nation - Homepage", "sourceType": "external", "usedBy": [ { "type": "market-source", "title": "State of the Australian peptide market", "url": "https://peptidecheck.com.au/state-of-market/", "context": "SARM Nation presents SARMs and peptides for laboratory research with third-party verified, batch-specific COA language and Australian dispatch claims." }, { "type": "vendor", "title": "SARM Nation", "url": "https://peptidecheck.com.au/vendors/sarm-nation/", "context": "Public SARM Nation homepage recorded 2026-05-19." } ], "usedByCount": 2 }, { "url": "https://sarmsaustralia.com/", "label": "SARMs Australia - Homepage", "sourceType": "external", "usedBy": [ { "type": "market-source", "title": "State of the Australian peptide market", "url": "https://peptidecheck.com.au/state-of-market/", "context": "SARMs Australia resolves but redirects Australian requests to a geoblocked page in this record, so product-level evidence remains pending." }, { "type": "vendor", "title": "SARMs Australia", "url": "https://peptidecheck.com.au/vendors/sarms-australia/", "context": "Public domain check from Australia recorded 2026-05-19; homepage redirected to /geoblocked/." } ], "usedByCount": 2 }, { "url": "https://southernlabs.com.au/", "label": "Southern Labs - Homepage", "sourceType": "external", "usedBy": [ { "type": "market-source", "title": "State of the Australian peptide market", "url": "https://peptidecheck.com.au/state-of-market/", "context": "Southern Labs presents research-use-only peptides with same-day Adelaide dispatch, COA included, bundle stacks, and HPLC purity claims." }, { "type": "vendor", "title": "Southern Labs", "url": "https://peptidecheck.com.au/vendors/southern-labs/", "context": "Public Southern Labs homepage recorded 2026-05-19." } ], "usedByCount": 2 }, { "url": "https://stackpure.is/", "label": "Stackpure - Homepage", "sourceType": "external", "usedBy": [ { "type": "guide", "title": "International Peptide Vendor Australia Shipping Risk", "url": "https://peptidecheck.com.au/guides/international-peptide-vendor-australia-shipping-risk/", "context": "How Australian buyers can assess overseas peptide vendors, global shipping claims, Bitcoin payment, import risk, customs labels, and COA proof before ordering." }, { "type": "market-source", "title": "State of the Australian peptide market", "url": "https://peptidecheck.com.au/state-of-market/", "context": "Stackpure presents global peptide shipping including Australia, 99% HPLC purity, independent COA every batch, cGMP certification, Bitcoin payment, and a stack-builder flow." }, { "type": "vendor", "title": "Stackpure", "url": "https://peptidecheck.com.au/vendors/stackpure/", "context": "Public Stackpure homepage recorded 2026-05-19." } ], "usedByCount": 3 }, { "url": "https://thenadclinic.au/bpc-157-capsules", "label": "The NAD Clinic BPC-157 capsules page", "sourceType": "external", "usedBy": [ { "type": "vendor", "title": "The NAD Clinic", "url": "https://peptidecheck.com.au/vendors/the-nad-clinic/", "context": "Public The NAD Clinic BPC-157 page recorded 2026-05-19." } ], "usedByCount": 1 }, { "url": "https://thepublicsradio.org/npr/influencers-are-promoting-peptides-for-better-health-whats-the-science-say/", "label": "NPR / The Public's Radio - Influencers are promoting peptides", "sourceType": "external", "usedBy": [ { "type": "guide", "title": "Peptide Creator Affiliate Disclosure Standard", "url": "https://peptidecheck.com.au/guides/peptide-creator-affiliate-disclosure-standard/", "context": "A public disclosure checklist for Australian peptide creators, TikTok codes, podcast recommendations, influencer testimonials, and affiliate-linked vendor promotion." }, { "type": "market-source", "title": "State of the Australian peptide market", "url": "https://peptidecheck.com.au/state-of-market/", "context": "Reports influencer-driven peptide promotion and uncertainty around science, income disclosures, and product claims." } ], "usedByCount": 2 }, { "url": "https://theweek.com/health/peptides-injectables-grey-market-synthetic-wellness", "label": "The Week - The regulation issues with grey-market peptides", "sourceType": "external", "usedBy": [ { "type": "market-source", "title": "State of the Australian peptide market", "url": "https://peptidecheck.com.au/state-of-market/", "context": "Summarizes reporting that US imports of hormone and peptide compounds from China reached US$328M in the first three quarters of 2025, up from US$164M in the prior-year period." } ], "usedByCount": 1 }, { "url": "https://time.com/7380810/anti-aging-peptide-shots-social-media/", "label": "TIME - What to Know About Anti-Aging Peptide Shots Flooding Social Media", "sourceType": "external", "usedBy": [ { "type": "market-source", "title": "State of the Australian peptide market", "url": "https://peptidecheck.com.au/state-of-market/", "context": "Reports that wellness enthusiasts, biohackers, influencers, and celebrities are driving mainstream peptide attention while many products remain grey-market or unapproved." } ], "usedByCount": 1 }, { "url": "https://vantalab.com.au/product/bpc-157", "label": "VantaLab - BPC-157 product page", "sourceType": "external", "usedBy": [ { "type": "guide", "title": "Peptide COA Library Verification Standard", "url": "https://peptidecheck.com.au/guides/coa-library-verification-standard/", "context": "How to audit a peptide vendor's COA library, certificate links, batch reports, lab identity, test dates, HPLC data, and product-to-vial matching before trusting purity claims." }, { "type": "market-source", "title": "State of the Australian peptide market", "url": "https://peptidecheck.com.au/state-of-market/", "context": "VantaLab's BPC-157 product page shows research-use-only language, 99%+ purity, COA included, Express Post, visible pricing, and a certificate-link surface." }, { "type": "vendor", "title": "VantaLab", "url": "https://peptidecheck.com.au/vendors/vantalab/", "context": "Public VantaLab BPC-157 product page recorded 2026-05-19." } ], "usedByCount": 3 }, { "url": "https://vicorpus.com/", "label": "ViCorpus - Homepage", "sourceType": "external", "usedBy": [ { "type": "market-source", "title": "State of the Australian peptide market", "url": "https://peptidecheck.com.au/state-of-market/", "context": "ViCorpus lists SARMs/PCTs, Peptides, BPC-157, bacteriostatic water, and third-party-testing language on its public homepage." }, { "type": "vendor", "title": "ViCorpus", "url": "https://peptidecheck.com.au/vendors/vicorpus/", "context": "Public ViCorpus homepage recorded 2026-05-19." } ], "usedByCount": 2 }, { "url": "https://www.accc.gov.au/media-release/accc-social-media-sweep-targets-influencers", "label": "ACCC - Social media influencers sweep", "sourceType": "external", "usedBy": [ { "type": "guide", "title": "Peptide Creator Affiliate Disclosure Standard", "url": "https://peptidecheck.com.au/guides/peptide-creator-affiliate-disclosure-standard/", "context": "A public disclosure checklist for Australian peptide creators, TikTok codes, podcast recommendations, influencer testimonials, and affiliate-linked vendor promotion." }, { "type": "market-source", "title": "State of the Australian peptide market", "url": "https://peptidecheck.com.au/state-of-market/", "context": "ACCC announced a sweep of social media influencers to identify misleading testimonials and endorsements." } ], "usedByCount": 2 }, { "url": "https://www.accc.gov.au/system/files/social-media-influencer-testimonials.pdf", "label": "ACCC - Social media influencer testimonials guidance", "sourceType": "external", "usedBy": [ { "type": "guide", "title": "Peptide Creator Affiliate Disclosure Standard", "url": "https://peptidecheck.com.au/guides/peptide-creator-affiliate-disclosure-standard/", "context": "A public disclosure checklist for Australian peptide creators, TikTok codes, podcast recommendations, influencer testimonials, and affiliate-linked vendor promotion." }, { "type": "market-source", "title": "State of the Australian peptide market", "url": "https://peptidecheck.com.au/state-of-market/", "context": "ACCC guidance covers social media influencer testimonials and endorsement-risk signals for businesses and creators." } ], "usedByCount": 2 }, { "url": "https://www.ahpra.gov.au/Registration/Registers-of-Practitioners.aspx", "label": "Ahpra - Register of practitioners", "sourceType": "external", "usedBy": [ { "type": "guide", "title": "Clinic and Telehealth Peptide Pathway Check", "url": "https://peptidecheck.com.au/guides/clinic-telehealth-peptide-pathway-check/", "context": "How to inspect Australian peptide clinic, telehealth, pharmacy, prescription, practitioner, and compounding claims before trusting a medical pathway." }, { "type": "market-source", "title": "State of the Australian peptide market", "url": "https://peptidecheck.com.au/state-of-market/", "context": "Ahpra provides public registration lookup for health practitioners in Australia." } ], "usedByCount": 2 }, { "url": "https://www.auspeptidewarehouse.com.au/coa", "label": "Peptide Warehouse COA library", "sourceType": "external", "usedBy": [ { "type": "vendor", "title": "Peptide Warehouse Australia", "url": "https://peptidecheck.com.au/vendors/peptide-warehouse-australia/", "context": "Public Peptide Warehouse product and COA pages recorded 2026-05-19." } ], "usedByCount": 1 }, { "url": "https://www.auspeptidewarehouse.com.au/products/bpc-157-tb-500-blend", "label": "Peptide Warehouse BPC-157 + TB-500 product page", "sourceType": "external", "usedBy": [ { "type": "vendor", "title": "Peptide Warehouse Australia", "url": "https://peptidecheck.com.au/vendors/peptide-warehouse-australia/", "context": "Public Peptide Warehouse product and COA pages recorded 2026-05-19." } ], "usedByCount": 1 }, { "url": "https://www.aussiepeptides.au/homepage", "label": "Aussie Peptides - Homepage", "sourceType": "external", "usedBy": [ { "type": "guide", "title": "Peptide COA Library Verification Standard", "url": "https://peptidecheck.com.au/guides/coa-library-verification-standard/", "context": "How to audit a peptide vendor's COA library, certificate links, batch reports, lab identity, test dates, HPLC data, and product-to-vial matching before trusting purity claims." }, { "type": "market-source", "title": "State of the Australian peptide market", "url": "https://peptidecheck.com.au/state-of-market/", "context": "Aussie Peptides presents local Australian stock, same-business-day dispatch, COA every batch, and HPLC-purity claims." }, { "type": "vendor", "title": "Aussie Peptides", "url": "https://peptidecheck.com.au/vendors/aussie-peptides/", "context": "Public Aussie Peptides homepage recorded 2026-05-19." } ], "usedByCount": 3 }, { "url": "https://www.fda.gov/drugs/postmarket-drug-safety-information-patients-and-providers/fdas-concerns-unapproved-glp-1-drugs-used-weight-loss", "label": "FDA - Concerns with unapproved GLP-1 drugs", "sourceType": "external", "usedBy": [ { "type": "guide", "title": "Counterfeit Peptide Detection Guide", "url": "https://peptidecheck.com.au/counterfeit-detection-guide/", "context": "How to check peptide and GLP-1 vials for counterfeit risk using batch-matched COAs, lab verification, QR destinations, reverse-image checks, and dose-quantity proof." }, { "type": "market-source", "title": "State of the Australian peptide market", "url": "https://peptidecheck.com.au/state-of-market/", "context": "FDA states retatrutide and cagrilintide cannot be used in compounding under US federal law and warns counterfeit products may contain wrong, too little, too much, or no active ingredient." } ], "usedByCount": 2 }, { "url": "https://www.grandviewresearch.com/horizon/outlook/peptide-therapeutics-market/australia", "label": "Grand View Research - Australia Peptide Therapeutics Market Size & Outlook", "sourceType": "external", "usedBy": [ { "type": "market-source", "title": "State of the Australian peptide market", "url": "https://peptidecheck.com.au/state-of-market/", "context": "Public page states Australia peptide therapeutics revenue of US$1,906.3M in 2025, projected US$3,711.1M by 2033, at 7.8% CAGR from 2026 to 2033." } ], "usedByCount": 1 }, { "url": "https://www.gzeromedia.com/news/analysis/how-china-is-supplying-americas-biohacking-craze", "label": "GZERO Media - How China is supplying America's biohacking craze", "sourceType": "external", "usedBy": [ { "type": "market-source", "title": "State of the Australian peptide market", "url": "https://peptidecheck.com.au/state-of-market/", "context": "Reports the same near-doubling of US hormone and peptide compound imports from China in 2025." } ], "usedByCount": 1 }, { "url": "https://www.lilly.com/medicines/safety/counterfeit", "label": "Eli Lilly - Identify real Lilly medicine", "sourceType": "external", "usedBy": [ { "type": "guide", "title": "Counterfeit Peptide Detection Guide", "url": "https://peptidecheck.com.au/counterfeit-detection-guide/", "context": "How to check peptide and GLP-1 vials for counterfeit risk using batch-matched COAs, lab verification, QR destinations, reverse-image checks, and dose-quantity proof." }, { "type": "market-source", "title": "State of the Australian peptide market", "url": "https://peptidecheck.com.au/state-of-market/", "context": "Lilly's counterfeit-medicine page warns that fake or counterfeit GLP-1 products are promoted online and may contain insulin, saline, or unknown products." } ], "usedByCount": 2 }, { "url": "https://www.mcdermottlaw.com/wp-content/uploads/2026/04/Presentation-Materials-Peptides-Under-the-Microscope-Regulation-Enforcement-and-Market-Implications.pdf", "label": "McDermott Will & Schulte - Peptides Under the Microscope, April 2026", "sourceType": "external", "usedBy": [ { "type": "market-source", "title": "State of the Australian peptide market", "url": "https://peptidecheck.com.au/state-of-market/", "context": "Presentation cites global peptide therapeutics at US$140.86B in 2025 and US$294.58B projected for 2033." } ], "usedByCount": 1 }, { "url": "https://www.nbcrightnow.com/national/looksmaxxing-exposes-the-darker-side-of-glow-up-culture/article_a22dca19-d7b9-5d34-a9ae-6dbef476d57b.html", "label": "Looksmaxxing exposes the darker side of glow-up culture", "sourceType": "external", "usedBy": [ { "type": "market-source", "title": "State of the Australian peptide market", "url": "https://peptidecheck.com.au/state-of-market/", "context": "Reports a Brandwatch analysis of more than 806,000 looksmaxxing mentions from September 2025 to early 2026, with mostly negative sentiment." } ], "usedByCount": 1 }, { "url": "https://www.nsw.gov.au/legal-and-justice/consumer-rights-and-protection/payments-loans-and-debts/credit-and-loans/disputing-card-transactions", "label": "NSW Government - Chargebacks", "sourceType": "external", "usedBy": [ { "type": "guide", "title": "Peptide Order Not Received Chargeback Australia", "url": "https://peptidecheck.com.au/guides/peptide-order-not-received-chargeback-australia/", "context": "What Australian peptide buyers should preserve when an order is not shipped, a vendor closes, a parcel is missing, or a support team stops replying." }, { "type": "market-source", "title": "State of the Australian peptide market", "url": "https://peptidecheck.com.au/state-of-market/", "context": "NSW Government explains chargebacks for card transactions, including situations where goods or services were not received or were not as described." } ], "usedByCount": 2 }, { "url": "https://www.peptidelab.com.au/", "label": "Peptide Lab public site", "sourceType": "external", "usedBy": [ { "type": "ownership", "title": "Ownership disclosure", "url": "https://peptidecheck.com.au/about/", "context": "Disclosed operator link" } ], "usedByCount": 1 }, { "url": "https://www.peptidelab.com.au/products", "label": "Peptide Lab public product catalogue", "sourceType": "external", "usedBy": [ { "type": "vendor", "title": "Peptide Lab", "url": "https://peptidecheck.com.au/vendors/peptide-lab/", "context": "Internal Peptide Lab product and batch records, 2026-05-17." }, { "type": "vendor", "title": "Peptide Lab", "url": "https://peptidecheck.com.au/vendors/peptide-lab/", "context": "Site clarity and terms: Public product pages are visible, but checkout terms and policy evidence still need a dedicated source audit." }, { "type": "vendor", "title": "Peptide Lab", "url": "https://peptidecheck.com.au/vendors/peptide-lab/", "context": "Product diversity: The public catalogue is linked, but category breadth should be scored against a dated SKU count." }, { "type": "vendor", "title": "Peptide Lab", "url": "https://peptidecheck.com.au/vendors/peptide-lab/", "context": "Pricing transparency: Pricing can be checked on public product pages. A final score still needs hidden-fee and checkout-path review." } ], "usedByCount": 4 }, { "url": "https://www.peptidesdirectaustralia.com/", "label": "Peptides Direct Australia - Homepage", "sourceType": "external", "usedBy": [ { "type": "guide", "title": "BPC-157 Price Check Australia", "url": "https://peptidecheck.com.au/guides/bpc-157-price-check-australia/", "context": "A dated price-intelligence snapshot for Australian BPC-157 searches, showing why cheap peptide pricing still needs batch, COA, lab, dispatch, and payment proof." }, { "type": "market-source", "title": "State of the Australian peptide market", "url": "https://peptidecheck.com.au/state-of-market/", "context": "Peptides Direct Australia presents a VIC-dispatched research peptide storefront with retatrutide, tirzepatide, BPC-157, GHK-Cu, starter kits, and AUD pricing." }, { "type": "vendor", "title": "Peptides Direct Australia", "url": "https://peptidecheck.com.au/vendors/peptides-direct-australia/", "context": "Public Peptides Direct Australia homepage recorded 2026-05-19." } ], "usedByCount": 3 }, { "url": "https://www.pharmacyboard.gov.au/Codes-Guidelines.aspx", "label": "Pharmacy Board of Australia - Codes and guidelines", "sourceType": "external", "usedBy": [ { "type": "guide", "title": "Clinic and Telehealth Peptide Pathway Check", "url": "https://peptidecheck.com.au/guides/clinic-telehealth-peptide-pathway-check/", "context": "How to inspect Australian peptide clinic, telehealth, pharmacy, prescription, practitioner, and compounding claims before trusting a medical pathway." }, { "type": "market-source", "title": "State of the Australian peptide market", "url": "https://peptidecheck.com.au/state-of-market/", "context": "The Pharmacy Board of Australia publishes codes, guidelines, and practice resources relevant to pharmacy conduct and standards." } ], "usedByCount": 2 }, { "url": "https://www.pillarresearch.com.au/", "label": "Pillar Research - Homepage", "sourceType": "external", "usedBy": [ { "type": "market-source", "title": "State of the Australian peptide market", "url": "https://peptidecheck.com.au/state-of-market/", "context": "Pillar Research presents a launching-soon Australian research peptide storefront with HPLC, mass-spectrometry, batch-specific COA, Australian stock, and same-day dispatch claims." }, { "type": "vendor", "title": "Pillar Research", "url": "https://peptidecheck.com.au/vendors/pillar-research/", "context": "Public Pillar Research homepage recorded 2026-05-19." } ], "usedByCount": 2 }, { "url": "https://www.retalabs.is/products", "label": "RetaLABS - Products page", "sourceType": "external", "usedBy": [ { "type": "guide", "title": "International Peptide Vendor Australia Shipping Risk", "url": "https://peptidecheck.com.au/guides/international-peptide-vendor-australia-shipping-risk/", "context": "How Australian buyers can assess overseas peptide vendors, global shipping claims, Bitcoin payment, import risk, customs labels, and COA proof before ordering." }, { "type": "market-source", "title": "State of the Australian peptide market", "url": "https://peptidecheck.com.au/state-of-market/", "context": "RetaLABS presents AU-targeted GLP-1 research compounds with COA-backed, manufacturer-verified, Express Post Australia-wide shipping language." }, { "type": "vendor", "title": "RetaLABS", "url": "https://peptidecheck.com.au/vendors/reta-labs/", "context": "Public RetaLABS products page recorded 2026-05-19." } ], "usedByCount": 3 }, { "url": "https://www.rgmed.com.au/terms-and-conditions/", "label": "Peptides Direct / RegenMed - Terms", "sourceType": "external", "usedBy": [ { "type": "guide", "title": "ABN and Operator Identity Check for Peptide Vendors", "url": "https://peptidecheck.com.au/guides/abn-operator-identity-check-peptides-australia/", "context": "How Australian peptide buyers can check ABN, business names, operator visibility, contact details, domain identity, and correction evidence before trusting a vendor." }, { "type": "market-source", "title": "State of the Australian peptide market", "url": "https://peptidecheck.com.au/state-of-market/", "context": "The terms page says Peptides Direct by RegenMed is owned and operated by COSMETICS 2U PTY LTD." }, { "type": "vendor", "title": "Peptides Direct", "url": "https://peptidecheck.com.au/vendors/peptides-direct/", "context": "Public Peptides Direct homepage recorded 2026-05-19." } ], "usedByCount": 3 }, { "url": "https://www.sportintegrity.gov.au/substances/growth-hormone", "label": "Sport Integrity Australia HGH information", "sourceType": "external", "usedBy": [ { "type": "regulatory", "title": "Australian Peptide Scheduling Map", "url": "https://peptidecheck.com.au/regulatory/peptide-scheduling-map/", "context": "The TGA says the Poisons Standard classifies medicines and poisons into schedules reflecting risk and recommended controls. Peptide Checker only marks a compound as scheduled where a primary TGA or government source is attached. Where the public record is a warning, advisory, or adjacent source rather than a schedule entry, the page says that plainly." } ], "usedByCount": 1 }, { "url": "https://www.tga.gov.au/database-adverse-event-notifications-daen", "label": "TGA - Database of Adverse Event Notifications", "sourceType": "external", "usedBy": [ { "type": "regulatory", "title": "Peptide Adverse Event Reporting Australia", "url": "https://peptidecheck.com.au/regulatory/adverse-event-reporting-peptides-australia/", "context": "The TGA's Database of Adverse Event Notifications, DAEN, is a public database of adverse event reports for medicines and vaccines. A report in DAEN does not prove that a medicine caused the event, but it can show safety signals that deserve careful review. Peptide Checker uses this page to explain what evidence buyers should preserve if they suspect harm from a peptide product." }, { "type": "market-source", "title": "State of the Australian peptide market", "url": "https://peptidecheck.com.au/state-of-market/", "context": "TGA describes the DAEN as a public database of adverse event notifications for medicines and vaccines." } ], "usedByCount": 2 }, { "url": "https://www.tga.gov.au/news/compliance-undertakings/enforceable-undertaking-net-pharmacy-pty-ltd", "label": "TGA Net Pharmacy enforceable undertaking", "sourceType": "external", "usedBy": [ { "type": "regulatory", "title": "Australian Peptide Scheduling Map", "url": "https://peptidecheck.com.au/regulatory/peptide-scheduling-map/", "context": "The TGA says the Poisons Standard classifies medicines and poisons into schedules reflecting risk and recommended controls. Peptide Checker only marks a compound as scheduled where a primary TGA or government source is attached. Where the public record is a warning, advisory, or adjacent source rather than a schedule entry, the page says that plainly." } ], "usedByCount": 1 }, { "url": "https://www.tga.gov.au/news/media-releases/10-million-penalty-ordered-against-peptide-clinics-pty-ltd-advertising-breaches", "label": "TGA - $10 million Peptide Clinics penalty", "sourceType": "external", "usedBy": [ { "type": "regulatory", "title": "TGA Peptide Enforcement Tracker", "url": "https://peptidecheck.com.au/regulatory/tga-enforcement-tracker/", "context": "The current tracker records 9 public TGA actions relevant to the peptide and adjacent clinic-market trust problem. Monetary penalties and infringement notices visible in the tracker total at least $10,242,748, excluding the Your Solution Compounding Pharmacy undertaking because no penalty amount is attached to that public record." }, { "type": "market-source", "title": "State of the Australian peptide market", "url": "https://peptidecheck.com.au/state-of-market/", "context": "TGA says the Federal Court ordered Peptide Clinics Australia, Peptide Clinics Pty Ltd, to pay $10 million for advertising breaches involving medicines, including prescription-only medicines." }, { "type": "vendor", "title": "Peptide Clinics Pty Ltd", "url": "https://peptidecheck.com.au/vendors/peptide-clinics-pty-ltd/", "context": "TGA Federal Court penalty media release recorded 2026-05-19." } ], "usedByCount": 3 }, { "url": "https://www.tga.gov.au/news/media-releases/carusos-natural-health-pty-ltd-fined-alleged-offences-relating-regulatory-requirements", "label": "TGA - Caruso's Natural Health 2024 infringement notices", "sourceType": "external", "usedBy": [ { "type": "regulatory", "title": "TGA Peptide Enforcement Tracker", "url": "https://peptidecheck.com.au/regulatory/tga-enforcement-tracker/", "context": "The current tracker records 9 public TGA actions relevant to the peptide and adjacent clinic-market trust problem. Monetary penalties and infringement notices visible in the tracker total at least $10,242,748, excluding the Your Solution Compounding Pharmacy undertaking because no penalty amount is attached to that public record." }, { "type": "market-source", "title": "State of the Australian peptide market", "url": "https://peptidecheck.com.au/state-of-market/", "context": "TGA issued five infringement notices totalling $82,500 to Caruso's Natural Health Pty Ltd for alleged failure to hold evidence supporting therapeutic uses in listed medicines." } ], "usedByCount": 2 }, { "url": "https://www.tga.gov.au/news/media-releases/nsw-based-individual-issued-infringement-notices-allegedly-importing-cosmetic-injectables", "label": "TGA - NSW-based individual infringement notices", "sourceType": "external", "usedBy": [ { "type": "regulatory", "title": "TGA Peptide Enforcement Tracker", "url": "https://peptidecheck.com.au/regulatory/tga-enforcement-tracker/", "context": "The current tracker records 9 public TGA actions relevant to the peptide and adjacent clinic-market trust problem. Monetary penalties and infringement notices visible in the tracker total at least $10,242,748, excluding the Your Solution Compounding Pharmacy undertaking because no penalty amount is attached to that public record." }, { "type": "market-source", "title": "State of the Australian peptide market", "url": "https://peptidecheck.com.au/state-of-market/", "context": "TGA issued 5 infringement notices totalling $19,800 to a NSW-based individual for alleged unlawful importation of unapproved prescription-only medicines." } ], "usedByCount": 2 }, { "url": "https://www.tga.gov.au/news/media-releases/nsw-person-fined-2664-alleged-unlawful-import-prescription-medicines", "label": "TGA - NSW $2,664 import infringement", "sourceType": "external", "usedBy": [ { "type": "regulatory", "title": "TGA Peptide Enforcement Tracker", "url": "https://peptidecheck.com.au/regulatory/tga-enforcement-tracker/", "context": "The current tracker records 9 public TGA actions relevant to the peptide and adjacent clinic-market trust problem. Monetary penalties and infringement notices visible in the tracker total at least $10,242,748, excluding the Your Solution Compounding Pharmacy undertaking because no penalty amount is attached to that public record." }, { "type": "market-source", "title": "State of the Australian peptide market", "url": "https://peptidecheck.com.au/state-of-market/", "context": "TGA issued a $2,664 infringement notice to a NSW-based medical practitioner for alleged unlawful importation of a prescription-only medicine." } ], "usedByCount": 2 }, { "url": "https://www.tga.gov.au/news/media-releases/tga-continues-action-against-peptide-clinics-australia-alleged-advertising-breaches", "label": "TGA earlier Peptide Clinics court-action update", "sourceType": "external", "usedBy": [ { "type": "vendor", "title": "Peptide Clinics Pty Ltd", "url": "https://peptidecheck.com.au/vendors/peptide-clinics-pty-ltd/", "context": "TGA Federal Court penalty media release recorded 2026-05-19." } ], "usedByCount": 1 }, { "url": "https://www.tga.gov.au/news/media-releases/tga-issues-infringement-notices-6-individuals-alleged-importation-and-unlawful-advertising-therapeutic-goods", "label": "TGA - 6 individuals infringement notices", "sourceType": "external", "usedBy": [ { "type": "regulatory", "title": "TGA Peptide Enforcement Tracker", "url": "https://peptidecheck.com.au/regulatory/tga-enforcement-tracker/", "context": "The current tracker records 9 public TGA actions relevant to the peptide and adjacent clinic-market trust problem. Monetary penalties and infringement notices visible in the tracker total at least $10,242,748, excluding the Your Solution Compounding Pharmacy undertaking because no penalty amount is attached to that public record." }, { "type": "market-source", "title": "State of the Australian peptide market", "url": "https://peptidecheck.com.au/state-of-market/", "context": "TGA issued 11 infringement notices totalling $43,560 to 6 individuals for alleged unlawful importation of unapproved therapeutic goods and alleged unlawful advertising." } ], "usedByCount": 2 }, { "url": "https://www.tga.gov.au/news/media-releases/tga-issues-infringement-notices-alleged-unlawful-advertising-therapeutic-goods-involving-prohibited-representations", "label": "TGA - Switch Nutrition infringement notices", "sourceType": "external", "usedBy": [ { "type": "regulatory", "title": "TGA Peptide and Compounding Enforcement Actions", "url": "https://peptidecheck.com.au/regulatory/tga-enforcement-actions-2026/", "context": "Peptide Checker does not apply an enforcement penalty to a vendor unless the public source is attached to that vendor profile. This index records market-relevant TGA actions and explains how each case should and should not be used." }, { "type": "regulatory", "title": "TGA Peptide Enforcement Tracker", "url": "https://peptidecheck.com.au/regulatory/tga-enforcement-tracker/", "context": "The current tracker records 9 public TGA actions relevant to the peptide and adjacent clinic-market trust problem. Monetary penalties and infringement notices visible in the tracker total at least $10,242,748, excluding the Your Solution Compounding Pharmacy undertaking because no penalty amount is attached to that public record." }, { "type": "market-source", "title": "State of the Australian peptide market", "url": "https://peptidecheck.com.au/state-of-market/", "context": "TGA issued 4 infringement notices totalling $79,200 to Switch Nutrition Pty Ltd for alleged unlawful advertising of therapeutic goods." } ], "usedByCount": 3 }, { "url": "https://www.tga.gov.au/news/media-releases/three-victorians-arrested-following-seizure-over-2-million-worth-steroids-and-peptides-abf-and-tga", "label": "TGA and ABF - Three Victorians arrested after steroids and peptides seizure", "sourceType": "external", "usedBy": [ { "type": "regulatory", "title": "Peptide Customs Seizure Australia", "url": "https://peptidecheck.com.au/regulatory/customs-seizure-explained/", "context": "The TGA warns that unapproved peptide products with unclear labelling, code-only identification, omitted ingredients, obscured information, or unlabelled vials may not be considered for release under the Personal Importation Scheme. A joint ABF/TGA release in April 2026 also reported seizures of PIEDs, steroids, and peptide products in an alleged importation syndicate investigation." }, { "type": "regulatory", "title": "TGA Peptide and Compounding Enforcement Actions", "url": "https://peptidecheck.com.au/regulatory/tga-enforcement-actions-2026/", "context": "Peptide Checker does not apply an enforcement penalty to a vendor unless the public source is attached to that vendor profile. This index records market-relevant TGA actions and explains how each case should and should not be used." }, { "type": "market-source", "title": "State of the Australian peptide market", "url": "https://peptidecheck.com.au/state-of-market/", "context": "Joint ABF/TGA release says more than $2M worth of PIEDs, steroids and peptide products were seized in an alleged importation syndicate investigation." } ], "usedByCount": 3 }, { "url": "https://www.tga.gov.au/news/media-releases/update-glucagon-peptide-1-receptor-agonists-glp-1-ras-pharmacy-compounding-changes", "label": "TGA - GLP-1 RA pharmacy compounding changes", "sourceType": "external", "usedBy": [ { "type": "regulatory", "title": "GLP-1 Compounding Ban Australia 2024", "url": "https://peptidecheck.com.au/regulatory/glp1-compounding-ban-2024-au/", "context": "The TGA says amendments to the Therapeutic Goods Regulations 1990 mean compounded GLP-1 RA products are no longer able to be compounded by pharmacists and supplied to patients. The change applies to GLP-1 RA analogues compounded on or after 1 October 2024." }, { "type": "market-source", "title": "State of the Australian peptide market", "url": "https://peptidecheck.com.au/state-of-market/", "context": "TGA states amendments apply to medicines containing GLP-1 RA analogues compounded on or after 1 October 2024." } ], "usedByCount": 2 }, { "url": "https://www.tga.gov.au/news/media-releases/victorian-fined-allegedly-importing-unapproved-peptide", "label": "TGA - Victorian fined for allegedly importing unapproved peptide", "sourceType": "external", "usedBy": [ { "type": "regulatory", "title": "TGA Peptide and Compounding Enforcement Actions", "url": "https://peptidecheck.com.au/regulatory/tga-enforcement-actions-2026/", "context": "Peptide Checker does not apply an enforcement penalty to a vendor unless the public source is attached to that vendor profile. This index records market-relevant TGA actions and explains how each case should and should not be used." }, { "type": "regulatory", "title": "TGA Peptide Enforcement Tracker", "url": "https://peptidecheck.com.au/regulatory/tga-enforcement-tracker/", "context": "The current tracker records 9 public TGA actions relevant to the peptide and adjacent clinic-market trust problem. Monetary penalties and infringement notices visible in the tracker total at least $10,242,748, excluding the Your Solution Compounding Pharmacy undertaking because no penalty amount is attached to that public record." }, { "type": "market-source", "title": "State of the Australian peptide market", "url": "https://peptidecheck.com.au/state-of-market/", "context": "TGA issued one $3,756 infringement notice to a Victoria-based individual for alleged unlawful importation of a peptide." } ], "usedByCount": 3 }, { "url": "https://www.tga.gov.au/news/media-releases/victorian-issued-further-infringement-notices-allegedly-importing-unapproved-therapeutic-goods", "label": "TGA Victorian further infringement notices", "sourceType": "external", "usedBy": [ { "type": "regulatory", "title": "TGA Peptide and Compounding Enforcement Actions", "url": "https://peptidecheck.com.au/regulatory/tga-enforcement-actions-2026/", "context": "Peptide Checker does not apply an enforcement penalty to a vendor unless the public source is attached to that vendor profile. This index records market-relevant TGA actions and explains how each case should and should not be used." }, { "type": "regulatory", "title": "TGA Peptide Enforcement Tracker", "url": "https://peptidecheck.com.au/regulatory/tga-enforcement-tracker/", "context": "The current tracker records 9 public TGA actions relevant to the peptide and adjacent clinic-market trust problem. Monetary penalties and infringement notices visible in the tracker total at least $10,242,748, excluding the Your Solution Compounding Pharmacy undertaking because no penalty amount is attached to that public record." } ], "usedByCount": 2 }, { "url": "https://www.tga.gov.au/news/media-releases/your-solution-compounding-pharmacy-undertakes-comply-advertising-rules-weight-loss-medicines", "label": "TGA - Your Solution Compounding Pharmacy undertaking", "sourceType": "external", "usedBy": [ { "type": "regulatory", "title": "GLP-1 Compounding Ban Australia 2024", "url": "https://peptidecheck.com.au/regulatory/glp1-compounding-ban-2024-au/", "context": "The TGA says amendments to the Therapeutic Goods Regulations 1990 mean compounded GLP-1 RA products are no longer able to be compounded by pharmacists and supplied to patients. The change applies to GLP-1 RA analogues compounded on or after 1 October 2024." }, { "type": "regulatory", "title": "TGA Peptide and Compounding Enforcement Actions", "url": "https://peptidecheck.com.au/regulatory/tga-enforcement-actions-2026/", "context": "Peptide Checker does not apply an enforcement penalty to a vendor unless the public source is attached to that vendor profile. This index records market-relevant TGA actions and explains how each case should and should not be used." }, { "type": "regulatory", "title": "TGA Peptide Enforcement Tracker", "url": "https://peptidecheck.com.au/regulatory/tga-enforcement-tracker/", "context": "The current tracker records 9 public TGA actions relevant to the peptide and adjacent clinic-market trust problem. Monetary penalties and infringement notices visible in the tracker total at least $10,242,748, excluding the Your Solution Compounding Pharmacy undertaking because no penalty amount is attached to that public record." }, { "type": "market-source", "title": "State of the Australian peptide market", "url": "https://peptidecheck.com.au/state-of-market/", "context": "TGA accepted a court-enforceable undertaking regarding advertising of prescription-only compounded medicines for weight loss." } ], "usedByCount": 4 }, { "url": "https://www.tga.gov.au/products/importing-medicine-or-medical-device", "label": "TGA importing medicine or medical device", "sourceType": "external", "usedBy": [ { "type": "regulatory", "title": "Personal Importation Scheme Peptides Australia 2026", "url": "https://peptidecheck.com.au/regulatory/personal-importation-scheme-2026/", "context": "The TGA says the Personal Importation Scheme can allow individuals to import therapeutic goods not entered in the ARTG only if all conditions are met. Those conditions include personal or immediate-family use, no supply to anyone else, a valid Australian prescription or written authority for prescription-only medicines, no more than a 3-month supply in a single order, no more than a 15-month supply in 12 months, no controlled substances, and clear labels. Counterfeit products are prohibited under any circumstances." } ], "usedByCount": 1 }, { "url": "https://www.tga.gov.au/products/regulations-all-products/advertising/advertising-basics", "label": "TGA - Advertising basics for therapeutic goods", "sourceType": "external", "usedBy": [ { "type": "regulatory", "title": "Peptide Advertising Claims Australia", "url": "https://peptidecheck.com.au/regulatory/peptide-advertising-claims-australia/", "context": "The TGA regulates advertising of therapeutic goods in Australia and explains that some goods, including prescription medicines and other restricted goods, cannot be advertised to the public. For peptide buyers, the practical check is whether a page turns research, wellness, recovery, fat-loss, injury, hormone, or anti-ageing language into a therapeutic outcome claim before the evidence and lawful pathway are visible." }, { "type": "market-source", "title": "State of the Australian peptide market", "url": "https://peptidecheck.com.au/state-of-market/", "context": "TGA guidance explains the basics of advertising therapeutic goods in Australia and why advertisers need to comply with therapeutic-goods advertising rules." } ], "usedByCount": 2 }, { "url": "https://www.tga.gov.au/products/regulations-all-products/advertising/advertising-basics/what-can-and-cannot-be-advertised-general-public", "label": "TGA - Advertising prescription medicines and other restricted goods", "sourceType": "external", "usedBy": [ { "type": "regulatory", "title": "Peptide Advertising Claims Australia", "url": "https://peptidecheck.com.au/regulatory/peptide-advertising-claims-australia/", "context": "The TGA regulates advertising of therapeutic goods in Australia and explains that some goods, including prescription medicines and other restricted goods, cannot be advertised to the public. For peptide buyers, the practical check is whether a page turns research, wellness, recovery, fat-loss, injury, hormone, or anti-ageing language into a therapeutic outcome claim before the evidence and lawful pathway are visible." }, { "type": "market-source", "title": "State of the Australian peptide market", "url": "https://peptidecheck.com.au/state-of-market/", "context": "TGA explains what therapeutic goods can and cannot be advertised to the public, including prescription medicines and other restricted goods." } ], "usedByCount": 2 }, { "url": "https://www.tga.gov.au/products/unapproved-therapeutic-goods/access-pathways/personal-importation-scheme", "label": "TGA - Personal Importation Scheme", "sourceType": "external", "usedBy": [ { "type": "guide", "title": "International Peptide Vendor Australia Shipping Risk", "url": "https://peptidecheck.com.au/guides/international-peptide-vendor-australia-shipping-risk/", "context": "How Australian buyers can assess overseas peptide vendors, global shipping claims, Bitcoin payment, import risk, customs labels, and COA proof before ordering." }, { "type": "regulatory", "title": "Personal Importation Scheme Peptides Australia 2026", "url": "https://peptidecheck.com.au/regulatory/personal-importation-scheme-2026/", "context": "The TGA says the Personal Importation Scheme can allow individuals to import therapeutic goods not entered in the ARTG only if all conditions are met. Those conditions include personal or immediate-family use, no supply to anyone else, a valid Australian prescription or written authority for prescription-only medicines, no more than a 3-month supply in a single order, no more than a 15-month supply in 12 months, no controlled substances, and clear labels. Counterfeit products are prohibited under any circumstances." }, { "type": "market-source", "title": "State of the Australian peptide market", "url": "https://peptidecheck.com.au/state-of-market/", "context": "TGA says the Personal Importation Scheme applies only when all conditions are met, including personal or immediate-family use, prescription or written authority for prescription-only medicines, and the 3-month-per-order limit." } ], "usedByCount": 3 }, { "url": "https://www.tga.gov.au/resources/artg", "label": "TGA ARTG search", "sourceType": "external", "usedBy": [ { "type": "regulatory", "title": "ARTG Approved Peptide Medicines Australia", "url": "https://peptidecheck.com.au/regulatory/artg-approved-peptide-medicines/", "context": "The Australian Register of Therapeutic Goods, ARTG, is the public register for therapeutic goods that can be supplied in Australia. Buyers should use it to check product name, sponsor, active ingredients, dosage form, warnings, start date, and whether the product is listed, registered, included, or export-only. A research peptide storefront should not be treated as approved unless the exact product record supports that claim." } ], "usedByCount": 1 }, { "url": "https://www.tga.gov.au/resources/guidance/manufacturing-supplying-and-advertising-compounded-medicines-lawfully", "label": "TGA - Manufacturing, supplying and advertising compounded medicines lawfully", "sourceType": "external", "usedBy": [ { "type": "guide", "title": "Clinic and Telehealth Peptide Pathway Check", "url": "https://peptidecheck.com.au/guides/clinic-telehealth-peptide-pathway-check/", "context": "How to inspect Australian peptide clinic, telehealth, pharmacy, prescription, practitioner, and compounding claims before trusting a medical pathway." }, { "type": "market-source", "title": "State of the Australian peptide market", "url": "https://peptidecheck.com.au/state-of-market/", "context": "TGA guidance explains compounding, supply, advertising, GLP-1 analogue restrictions, IV therapy requirements, and exemptions." } ], "usedByCount": 2 }, { "url": "https://www.tga.gov.au/resources/legislation/poisons-standard", "label": "TGA - Poisons Standard overview", "sourceType": "external", "usedBy": [ { "type": "regulatory", "title": "Australian Peptide Scheduling Map", "url": "https://peptidecheck.com.au/regulatory/peptide-scheduling-map/", "context": "The TGA says the Poisons Standard classifies medicines and poisons into schedules reflecting risk and recommended controls. Peptide Checker only marks a compound as scheduled where a primary TGA or government source is attached. Where the public record is a warning, advisory, or adjacent source rather than a schedule entry, the page says that plainly." }, { "type": "market-source", "title": "State of the Australian peptide market", "url": "https://peptidecheck.com.au/state-of-market/", "context": "TGA explains that the Poisons Standard classifies medicines and poisons into schedules reflecting risk and recommended controls." } ], "usedByCount": 2 }, { "url": "https://www.tga.gov.au/safety/database-adverse-event-notifications-daen/tips-searching-database-adverse-event-notifications-daen", "label": "TGA - How to search the DAEN medicines", "sourceType": "external", "usedBy": [ { "type": "regulatory", "title": "Peptide Adverse Event Reporting Australia", "url": "https://peptidecheck.com.au/regulatory/adverse-event-reporting-peptides-australia/", "context": "The TGA's Database of Adverse Event Notifications, DAEN, is a public database of adverse event reports for medicines and vaccines. A report in DAEN does not prove that a medicine caused the event, but it can show safety signals that deserve careful review. Peptide Checker uses this page to explain what evidence buyers should preserve if they suspect harm from a peptide product." }, { "type": "market-source", "title": "State of the Australian peptide market", "url": "https://peptidecheck.com.au/state-of-market/", "context": "TGA explains how to search DAEN medicine reports and cautions that reports should be interpreted carefully." } ], "usedByCount": 2 }, { "url": "https://www.tga.gov.au/safety/safety-monitoring-and-information/safety-alerts/understanding-your-responsibilities-when-importing-compounding-and-supplying-unapproved-peptide-products", "label": "TGA - Understanding responsibilities for unapproved peptide products", "sourceType": "external", "usedBy": [ { "type": "guide", "title": "Counterfeit Peptide Detection Guide", "url": "https://peptidecheck.com.au/counterfeit-detection-guide/", "context": "How to check peptide and GLP-1 vials for counterfeit risk using batch-matched COAs, lab verification, QR destinations, reverse-image checks, and dose-quantity proof." }, { "type": "guide", "title": "International Peptide Vendor Australia Shipping Risk", "url": "https://peptidecheck.com.au/guides/international-peptide-vendor-australia-shipping-risk/", "context": "How Australian buyers can assess overseas peptide vendors, global shipping claims, Bitcoin payment, import risk, customs labels, and COA proof before ordering." }, { "type": "regulatory", "title": "ARTG Approved Peptide Medicines Australia", "url": "https://peptidecheck.com.au/regulatory/artg-approved-peptide-medicines/", "context": "The Australian Register of Therapeutic Goods, ARTG, is the public register for therapeutic goods that can be supplied in Australia. Buyers should use it to check product name, sponsor, active ingredients, dosage form, warnings, start date, and whether the product is listed, registered, included, or export-only. A research peptide storefront should not be treated as approved unless the exact product record supports that claim." }, { "type": "regulatory", "title": "Peptide Customs Seizure Australia", "url": "https://peptidecheck.com.au/regulatory/customs-seizure-explained/", "context": "The TGA warns that unapproved peptide products with unclear labelling, code-only identification, omitted ingredients, obscured information, or unlabelled vials may not be considered for release under the Personal Importation Scheme. A joint ABF/TGA release in April 2026 also reported seizures of PIEDs, steroids, and peptide products in an alleged importation syndicate investigation." }, { "type": "regulatory", "title": "Peptide Advertising Claims Australia", "url": "https://peptidecheck.com.au/regulatory/peptide-advertising-claims-australia/", "context": "The TGA regulates advertising of therapeutic goods in Australia and explains that some goods, including prescription medicines and other restricted goods, cannot be advertised to the public. For peptide buyers, the practical check is whether a page turns research, wellness, recovery, fat-loss, injury, hormone, or anti-ageing language into a therapeutic outcome claim before the evidence and lawful pathway are visible." }, { "type": "regulatory", "title": "Australian Peptide Scheduling Map", "url": "https://peptidecheck.com.au/regulatory/peptide-scheduling-map/", "context": "The TGA says the Poisons Standard classifies medicines and poisons into schedules reflecting risk and recommended controls. Peptide Checker only marks a compound as scheduled where a primary TGA or government source is attached. Where the public record is a warning, advisory, or adjacent source rather than a schedule entry, the page says that plainly." }, { "type": "regulatory", "title": "Personal Importation Scheme Peptides Australia 2026", "url": "https://peptidecheck.com.au/regulatory/personal-importation-scheme-2026/", "context": "The TGA says the Personal Importation Scheme can allow individuals to import therapeutic goods not entered in the ARTG only if all conditions are met. Those conditions include personal or immediate-family use, no supply to anyone else, a valid Australian prescription or written authority for prescription-only medicines, no more than a 3-month supply in a single order, no more than a 15-month supply in 12 months, no controlled substances, and clear labels. Counterfeit products are prohibited under any circumstances." }, { "type": "regulatory", "title": "TGA Peptide Watchlist Australia", "url": "https://peptidecheck.com.au/regulatory/tga-peptide-watchlist/", "context": "On 13 April 2026, the TGA published a safety advisory on unapproved peptide products. It names BPC-157, GHK-Cu, TB-500, retatrutide, and CJC-1295 as examples and warns that unclear labels, code-only products, research-use disclaimers, and public advertising can still create regulatory and public-health risk." }, { "type": "market-source", "title": "State of the Australian peptide market", "url": "https://peptidecheck.com.au/state-of-market/", "context": "TGA names BPC-157, GHK-Cu, TB-500, retatrutide and CJC-1295 as examples of unapproved peptide products and warns that unclear labelling/code-only products may not be released under the Personal Importation Scheme." } ], "usedByCount": 9 }, { "url": "https://www.tga.gov.au/searching-australian-register-therapeutic-goods-artg", "label": "TGA - Searching the Australian Register of Therapeutic Goods", "sourceType": "external", "usedBy": [ { "type": "regulatory", "title": "ARTG Approved Peptide Medicines Australia", "url": "https://peptidecheck.com.au/regulatory/artg-approved-peptide-medicines/", "context": "The Australian Register of Therapeutic Goods, ARTG, is the public register for therapeutic goods that can be supplied in Australia. Buyers should use it to check product name, sponsor, active ingredients, dosage form, warnings, start date, and whether the product is listed, registered, included, or export-only. A research peptide storefront should not be treated as approved unless the exact product record supports that claim." }, { "type": "market-source", "title": "State of the Australian peptide market", "url": "https://peptidecheck.com.au/state-of-market/", "context": "TGA provides public ARTG search for registered, listed, and included therapeutic goods that can be supplied in Australia." } ], "usedByCount": 2 }, { "url": "https://www.tga.gov.au/sites/default/files/2024-05/notice-final-decisions-amend-not-amend-current-poisons-standard-november-2023.pdf", "label": "TGA - BPC-157 final scheduling decision", "sourceType": "external", "usedBy": [ { "type": "regulatory", "title": "Australian Peptide Scheduling Map", "url": "https://peptidecheck.com.au/regulatory/peptide-scheduling-map/", "context": "The TGA says the Poisons Standard classifies medicines and poisons into schedules reflecting risk and recommended controls. Peptide Checker only marks a compound as scheduled where a primary TGA or government source is attached. Where the public record is a warning, advisory, or adjacent source rather than a schedule entry, the page says that plainly." }, { "type": "market-source", "title": "State of the Australian peptide market", "url": "https://peptidecheck.com.au/state-of-market/", "context": "TGA final decision created a Schedule 4 entry for BPC-157 in the Poisons Standard." } ], "usedByCount": 2 }, { "url": "https://www.tga.gov.au/sites/default/files/scheduling-delegates-interim-decisions-and-invitation-further-comment-accsacms-nov-2017.pdf", "label": "TGA - PIED scheduling decision excerpt", "sourceType": "external", "usedBy": [ { "type": "regulatory", "title": "Australian Peptide Scheduling Map", "url": "https://peptidecheck.com.au/regulatory/peptide-scheduling-map/", "context": "The TGA says the Poisons Standard classifies medicines and poisons into schedules reflecting risk and recommended controls. Peptide Checker only marks a compound as scheduled where a primary TGA or government source is attached. Where the public record is a warning, advisory, or adjacent source rather than a schedule entry, the page says that plainly." }, { "type": "market-source", "title": "State of the Australian peptide market", "url": "https://peptidecheck.com.au/state-of-market/", "context": "TGA scheduling material lists CJC-1295, pralmorelin/GHRP-2, GHRP-6, growth hormone releasing hormones, GHRPs, GHSs, hexarelin, ipamorelin, thymosin beta 4, TB-500, and fibroblast growth factors in Schedule 4 and Appendix D Part 5." } ], "usedByCount": 2 }, { "url": "https://www.thriverx.com.au/", "label": "Thrive Rx - Homepage", "sourceType": "external", "usedBy": [ { "type": "guide", "title": "Clinic and Telehealth Peptide Pathway Check", "url": "https://peptidecheck.com.au/guides/clinic-telehealth-peptide-pathway-check/", "context": "How to inspect Australian peptide clinic, telehealth, pharmacy, prescription, practitioner, and compounding claims before trusting a medical pathway." }, { "type": "market-source", "title": "State of the Australian peptide market", "url": "https://peptidecheck.com.au/state-of-market/", "context": "Thrive Rx says care is delivered by AHPRA-registered practitioners through TGA-compliant telehealth, with prescriptions not guaranteed." }, { "type": "vendor", "title": "Thrive Rx", "url": "https://peptidecheck.com.au/vendors/thrive-rx/", "context": "Public Thrive Rx homepage and peptide-therapy blog recorded 2026-05-19." } ], "usedByCount": 3 }, { "url": "https://www.thriverx.com.au/blog/a-safer-way-to-access-peptide-therapy-online-in-australia", "label": "Thrive Rx peptide therapy online article", "sourceType": "external", "usedBy": [ { "type": "vendor", "title": "Thrive Rx", "url": "https://peptidecheck.com.au/vendors/thrive-rx/", "context": "Public Thrive Rx homepage and peptide-therapy blog recorded 2026-05-19." } ], "usedByCount": 1 } ] }